🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 22 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/07/2005 29,69 29,77 29,26 29,68 +0,13% 1,74% 6.106.696
01/07/2005 29,39 29,91 29,39 29,64 +0,84% 1,79% 8.414.078
30/06/2005 29,96 29,96 29,20 29,39 -0,10% 2,55% 8.889.555
29/06/2005 29,58 29,62 29,29 29,42 -0,45% 1,10% 7.061.319
28/06/2005 29,37 29,69 29,20 29,55 +1,54% 1,69% 7.830.551
27/06/2005 29,01 29,47 29,01 29,10 -0,16% 1,58% 7.580.918
24/06/2005 29,70 29,79 29,06 29,15 -2,24% 2,47% 10.520.872
23/06/2005 30,45 30,45 29,79 29,82 -2,28% 2,16% 10.144.745
22/06/2005 30,76 30,76 30,45 30,52 -0,03% 1,02% 6.827.406
21/06/2005 30,73 30,80 30,42 30,52 -0,37% 1,24% 5.898.144
20/06/2005 30,53 30,81 30,46 30,64 -0,34% 1,16% 6.209.714
17/06/2005 31,01 31,01 30,41 30,74 +0,69% 1,94% 11.570.758
16/06/2005 30,53 30,70 30,43 30,53 +0,31% 0,88% 6.149.454
15/06/2005 30,29 30,53 30,09 30,44 +0,38% 1,48% 7.178.066
14/06/2005 30,11 30,39 30,02 30,32 +0,73% 1,24% 5.293.029
13/06/2005 29,60 30,22 29,59 30,11 +0,51% 2,13% 6.473.286
10/06/2005 29,87 30,05 29,66 29,95 +0,13% 1,31% 7.843.442
09/06/2005 30,06 30,18 29,82 29,91 -0,89% 1,21% 7.796.701
08/06/2005 30,70 30,70 30,13 30,18 -1,40% 1,83% 8.048.011
07/06/2005 30,57 30,91 30,51 30,61 +0,16% 1,31% 5.595.796
06/06/2005 30,59 30,64 30,45 30,56 -0,19% 0,62% 4.753.728
03/06/2005 30,75 30,75 30,44 30,62 -0,43% 1,02% 5.952.745
02/06/2005 30,70 30,77 30,53 30,75 +0,12% 0,78% 5.426.649
01/06/2005 30,73 30,92 30,45 30,72 -0,77% 1,52% 8.205.840
31/05/2005 30,96 31,06 30,80 30,95 -0,03% 0,83% 14.101.574
27/05/2005 30,92 31,09 30,83 30,96 +0,31% 0,83% 5.349.097
26/05/2005 31,19 31,19 30,74 30,87 -0,58% 1,44% 8.788.947
25/05/2005 31,25 31,37 30,97 31,05 -0,61% 1,28% 7.042.665
24/05/2005 31,36 31,73 31,24 31,24 +0,34% 1,55% 8.265.262
23/05/2005 31,01 31,45 30,99 31,14 +0,03% 1,48% 6.123.254